Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
October 31, 2024 18:54 ET
|
Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug Administration (FDA) Endocrinologic and...
The Tile Shop to Host Third Quarter 2024 Earnings Conference Call
October 31, 2024 17:00 ET
|
Tile Shop Holdings, Inc.
MINNEAPOLIS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone tiles, man-made and luxury vinyl tiles, setting and...
CPS Announces Third Quarter 2024 Earnings
October 31, 2024 16:30 ET
|
Consumer Portfolio Services, Inc.
Revenues of $100.6 million compared to $92.1 million in the prior year periodNet income of $4.8 million, or $0.20 per diluted shareTotal portfolio balance of $3.330 billion, highest in company...